PubRank

Chantal Mathieu

Author PubWeight™ 228.66‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Insulin needs after CD3-antibody therapy in new-onset type 1 diabetes. N Engl J Med 2005 10.16
2 Vitamin D and human health: lessons from vitamin D receptor null mice. Endocr Rev 2008 5.28
3 Vitamin D deficiency is highly prevalent in COPD and correlates with variants in the vitamin D-binding gene. Thorax 2009 4.86
4 High doses of vitamin D to reduce exacerbations in chronic obstructive pulmonary disease: a randomized trial. Ann Intern Med 2012 3.99
5 Interleukin-17 orchestrates the granulocyte influx into airways after allergen inhalation in a mouse model of allergic asthma. Am J Respir Cell Mol Biol 2003 3.60
6 Immunoregulation by 1,25-dihydroxyvitamin D3: basic concepts. J Steroid Biochem Mol Biol 2005 3.44
7 Vitamin D: modulator of the immune system. Curr Opin Pharmacol 2010 3.31
8 Initiation and execution of lipotoxic ER stress in pancreatic beta-cells. J Cell Sci 2008 2.99
9 Insulin degludec versus insulin glargine in insulin-naive patients with type 2 diabetes: a 1-year, randomized, treat-to-target trial (BEGIN Once Long). Diabetes Care 2012 2.89
10 A novel pathway combining calreticulin exposure and ATP secretion in immunogenic cancer cell death. EMBO J 2012 2.45
11 Insulin degludec, an ultra-long-acting basal insulin, once a day or three times a week versus insulin glargine once a day in patients with type 2 diabetes: a 16-week, randomised, open-label, phase 2 trial. Lancet 2011 2.34
12 Leaf mitochondria modulate whole cell redox homeostasis, set antioxidant capacity, and determine stress resistance through altered signaling and diurnal regulation. Plant Cell 2003 2.22
13 Sexual dysfunction in women with type 1 diabetes: a controlled study. Diabetes Care 2002 2.20
14 Polymorphisms in innate immunity genes predispose to bacteremia and death in the medical intensive care unit. Crit Care Med 2009 2.10
15 Monocytes from type 2 diabetic patients have a pro-inflammatory profile. 1,25-Dihydroxyvitamin D(3) works as anti-inflammatory. Diabetes Res Clin Pract 2006 1.84
16 Reversal of autoimmune diabetes by restoration of antigen-specific tolerance using genetically modified Lactococcus lactis in mice. J Clin Invest 2012 1.84
17 Prevalence and predictors of sexual dysfunction in patients with type 1 diabetes. Diabetes Care 2003 1.82
18 Vitamin D: a pleiotropic hormone. Kidney Int 2010 1.76
19 Vitamin D and cancer. J Steroid Biochem Mol Biol 2006 1.72
20 Cellular islet autoimmunity associates with clinical outcome of islet cell transplantation. PLoS One 2008 1.67
21 Vitamin D beyond bones in chronic obstructive pulmonary disease: time to act. Am J Respir Crit Care Med 2009 1.63
22 Correlation between beta cell mass and glycemic control in type 1 diabetic recipients of islet cell graft. Proc Natl Acad Sci U S A 2006 1.60
23 ROS-induced autophagy in cancer cells assists in evasion from determinants of immunogenic cell death. Autophagy 2013 1.55
24 Vitamin D and diabetes. Endocrinol Metab Clin North Am 2010 1.52
25 Toll-like receptor 3 and STAT-1 contribute to double-stranded RNA+ interferon-gamma-induced apoptosis in primary pancreatic beta-cells. J Biol Chem 2005 1.50
26 STAT1 is a master regulator of pancreatic {beta}-cell apoptosis and islet inflammation. J Biol Chem 2010 1.49
27 Optimal vitamin D status: a critical analysis on the basis of evidence-based medicine. J Clin Endocrinol Metab 2013 1.40
28 1,25-Dihydroxyvitamin D3 modulates expression of chemokines and cytokines in pancreatic islets: implications for prevention of diabetes in nonobese diabetic mice. Endocrinology 2005 1.39
29 Transient Epstein-Barr virus reactivation in CD3 monoclonal antibody-treated patients. Blood 2009 1.37
30 Immune regulation of 25-hydroxyvitamin-D3-1alpha-hydroxylase in human monocytes. J Bone Miner Res 2005 1.37
31 Survival benefits of intensive insulin therapy in critical illness: impact of maintaining normoglycemia versus glycemia-independent actions of insulin. Diabetes 2006 1.34
32 Regulation of vitamin D homeostasis: implications for the immune system. Nutr Rev 2008 1.33
33 Analogs of 1alpha,25-dihydroxyvitamin D3 as pluripotent immunomodulators. J Cell Biochem 2003 1.31
34 Vitamin D and diabetes: its importance for beta cell and immune function. Mol Cell Endocrinol 2011 1.30
35 The vitamin D receptor gene FokI polymorphism: functional impact on the immune system. Eur J Immunol 2007 1.28
36 Differences in baseline lymphocyte counts and autoreactivity are associated with differences in outcome of islet cell transplantation in type 1 diabetic patients. Diabetes 2009 1.27
37 Metabolic, endocrine, and immune effects of stress hyperglycemia in a rabbit model of prolonged critical illness. Endocrinology 2003 1.25
38 Cytokines tumor necrosis factor-α and interferon-γ induce pancreatic β-cell apoptosis through STAT1-mediated Bim protein activation. J Biol Chem 2011 1.20
39 Vitamin D insufficiency: implications for the immune system. Pediatr Nephrol 2010 1.18
40 Human T lymphocytes are direct targets of 1,25-dihydroxyvitamin D3 in the immune system. J Steroid Biochem Mol Biol 2010 1.18
41 The incidence of type 1 diabetes in the age group 0-39 years has not increased in Antwerp (Belgium) between 1989 and 2000: evidence for earlier disease manifestation. Diabetes Care 2002 1.16
42 Death protein 5 and p53-upregulated modulator of apoptosis mediate the endoplasmic reticulum stress-mitochondrial dialog triggering lipotoxic rodent and human β-cell apoptosis. Diabetes 2012 1.16
43 Vitamin D signaling in immune-mediated disorders: Evolving insights and therapeutic opportunities. Mol Aspects Med 2008 1.16
44 Islet infiltration, cytokine expression and beta cell death in the NOD mouse, BB rat, Komeda rat, LEW.1AR1-iddm rat and humans with type 1 diabetes. Diabetologia 2013 1.15
45 Double-stranded RNA induces pancreatic beta-cell apoptosis by activation of the toll-like receptor 3 and interferon regulatory factor 3 pathways. Diabetes 2008 1.14
46 Redirection of human autoreactive T-cells Upon interaction with dendritic cells modulated by TX527, an analog of 1,25 dihydroxyvitamin D(3). Diabetes 2002 1.13
47 Contribution of antibodies against IA-2β and zinc transporter 8 to classification of diabetes diagnosed under 40 years of age. Diabetes Care 2011 1.12
48 The vitamin D analog, TX527, promotes a human CD4+CD25highCD127low regulatory T cell profile and induces a migratory signature specific for homing to sites of inflammation. J Immunol 2010 1.12
49 Air pollution related prothrombotic changes in persons with diabetes. Environ Health Perspect 2010 1.11
50 Differential protein pathways in 1,25-dihydroxyvitamin d(3) and dexamethasone modulated tolerogenic human dendritic cells. J Proteome Res 2011 1.09
51 Disruption of the gamma-interferon signaling pathway at the level of signal transducer and activator of transcription-1 prevents immune destruction of beta-cells. Diabetes 2005 1.09
52 CCL27 is a critical factor for the development of atopic dermatitis in the keratin-14 IL-4 transgenic mouse model. Int Immunol 2006 1.08
53 Increased peritoneal and endometrial gene expression of biologically relevant cytokines and growth factors during the menstrual phase in women with endometriosis. Fertil Steril 2006 1.08
54 Patients' perceptions of subcutaneous insulin in the OPTIMIZE study: a multicenter follow-up study. Diabetes Technol Ther 2008 1.06
55 Vitamin D deficiency and chronic obstructive pulmonary disease: a vicious circle. Vitam Horm 2011 1.06
56 Proteomics analysis of cytokine-induced dysfunction and death in insulin-producing INS-1E cells: new insights into the pathways involved. Mol Cell Proteomics 2007 1.05
57 Vitamin D supplementation during rehabilitation in COPD: a secondary analysis of a randomized trial. Respir Res 2012 1.05
58 The effectiveness of hysteroscopy in improving pregnancy rates in subfertile women without other gynaecological symptoms: a systematic review. Hum Reprod Update 2009 1.03
59 Lack of respiratory chain complex I impairs alternative oxidase engagement and modulates redox signaling during elicitor-induced cell death in tobacco. Plant Cell 2007 1.03
60 Interdisciplinary diabetes care teams operating on the interface between primary and specialty care are associated with improved outcomes of care: findings from the Leuven Diabetes Project. BMC Health Serv Res 2009 1.02
61 Efficacy of vildagliptin versus sulfonylureas as add-on therapy to metformin: comparison of results from randomised controlled and observational studies. Diabetologia 2014 1.02
62 Inhibitory and stimulatory effects of cyclosporine A on the development of regulatory T cells in vivo. Transplantation 2005 1.01
63 IL-12 contributes to allergen-induced airway inflammation in experimental asthma. J Immunol 2006 1.01
64 GLP1 and cancer: friend or foe? Endocr Relat Cancer 2012 1.01
65 Blockade of CTLA-4 enhances allergic sensitization and eosinophilic airway inflammation in genetically predisposed mice. Eur J Immunol 2002 0.99
66 1alpha,25-dihydroxyvitamin D3 or analogue treated dendritic cells modulate human autoreactive T cells via the selective induction of apoptosis. J Autoimmun 2004 0.99
67 1,25-Dihydroxyvitamin D3 curtails the inflammatory and T cell stimulatory capacity of macrophages through an IL-10-dependent mechanism. Immunobiology 2012 0.98
68 Vitamin D3 and the immune system: maintaining the balance in health and disease. Nutr Res Rev 2007 0.98
69 High rate of Charcot foot attacks early after simultaneous pancreas-kidney transplantation. Transplantation 2007 0.97
70 Analysis of Pregnancy Outcomes Using the New IADPSG Recommendation Compared with the Carpenter and Coustan Criteria in an Area with a Low Prevalence of Gestational Diabetes. Int J Endocrinol 2013 0.97
71 Pharmacokinetics and antibody responses to the CD3 antibody otelixizumab used in the treatment of type 1 diabetes. J Clin Pharmacol 2010 0.96
72 Defect in activation-induced cell death in non-obese diabetic (NOD) T lymphocytes. J Autoimmun 2003 0.96
73 Interleukin-1 receptor-associated kinase-3 is a key inhibitor of inflammation in obesity and metabolic syndrome. PLoS One 2012 0.96
74 1,25-Dihydroxyvitamin D3 alters murine dendritic cell behaviour in vitro and in vivo. Diabetes Metab Res Rev 2011 0.96
75 Deletion of STAT-1 pancreatic islets protects against streptozotocin-induced diabetes and early graft failure but not against late rejection. Diabetes 2007 0.96
76 Development and validation of the Economic Assessment of Glycemic Control and Long-Term Effects of diabetes (EAGLE) model. Diabetes Technol Ther 2006 0.95
77 1,25-Dihydroxyvitamin D3 promotes tolerogenic dendritic cells with functional migratory properties in NOD mice. J Immunol 2014 0.95
78 The Vitamin D analogue TX 527 blocks NF-kappaB activation in peripheral blood mononuclear cells of patients with Crohn's disease. J Steroid Biochem Mol Biol 2006 0.95
79 Therapy with the hsp60 peptide DiaPep277 in C-peptide positive type 1 diabetes patients. Diabetes Metab Res Rev 2007 0.95
80 The effects of 1alpha,25-dihydroxyvitamin D3 on the expression of DNA replication genes. J Bone Miner Res 2004 0.94
81 Pancreatic duct cells in human islet cell preparations are a source of angiogenic cytokines interleukin-8 and vascular endothelial growth factor. Diabetes 2008 0.94
82 Decrease of miR-146b-5p in monocytes during obesity is associated with loss of the anti-inflammatory but not insulin signaling action of adiponectin. PLoS One 2012 0.94
83 A view on beta cell transplantation in diabetes. Ann N Y Acad Sci 2002 0.94
84 Immune regulation of 25-hydroxyvitamin D-1alpha-hydroxylase in human monocytic THP1 cells: mechanisms of interferon-gamma-mediated induction. J Clin Endocrinol Metab 2006 0.94
85 Unaltered diabetes presentation in NOD mice lacking the vitamin D receptor. Diabetes 2007 0.94
86 Feasibility, safety, and efficacy of percutaneous transhepatic injection of beta-cell grafts. J Vasc Interv Radiol 2005 0.93
87 Extraskeletal effects of vitamin D. Endocrinol Metab Clin North Am 2012 0.93
88 Targeting the NAD7 subunit to mitochondria restores a functional complex I and a wild type phenotype in the Nicotiana sylvestris CMS II mutant lacking nad7. J Biol Chem 2005 0.93
89 Barriers and facilitators to evidence based care of type 2 diabetes patients: experiences of general practitioners participating to a quality improvement program. Implement Sci 2009 0.92
90 Progesterone in gestational diabetes mellitus: guilty or not guilty? Trends Endocrinol Metab 2003 0.92
91 Vitamin D in autoimmune, infectious and allergic diseases: a vital player? Best Pract Res Clin Endocrinol Metab 2011 0.92
92 Cytokine signalling in the beta-cell: a dual role for IFNgamma. Biochem Soc Trans 2008 0.92
93 Novel insights in the immune function of the vitamin D system: synergism with interferon-beta. J Steroid Biochem Mol Biol 2006 0.91
94 Vitamin D and diabetes: the odd couple. Trends Endocrinol Metab 2013 0.91
95 Regulation of 25-hydroxyvitamin d-1alpha-hydroxylase by IFNgamma in human monocytic THP1 cells. J Steroid Biochem Mol Biol 2004 0.91
96 Modified aquaporin 5 expression and distribution in submandibular glands from NOD mice displaying autoimmune exocrinopathy. Arthritis Rheum 2007 0.90
97 Neuropeptides of the islets of Langerhans: a peptidomics study. Gen Comp Endocrinol 2007 0.90
98 Diabetic ketoacidosis. Rev Endocr Metab Disord 2003 0.90
99 Decreased miR-181a expression in monocytes of obese patients is associated with the occurrence of metabolic syndrome and coronary artery disease. J Clin Endocrinol Metab 2012 0.89
100 Patients with Type 2 Diabetes Initiating Exenatide Twice Daily or Insulin in Clinical Practice: CHOICE Study. Diabetes Ther 2012 0.89
101 Screening for pregestational and gestational diabetes in pregnancy: a survey of obstetrical centers in the northern part of Belgium. Diabetol Metab Syndr 2013 0.88
102 Lysine deacetylase inhibition prevents diabetes by chromatin-independent immunoregulation and β-cell protection. Proc Natl Acad Sci U S A 2014 0.88
103 Hepatocellular neoplasms induced by low-number pancreatic islet transplants in autoimmune diabetic BB/Pfd rats. Cancer Res 2006 0.88
104 Is vitamin D deficiency involved in the immune reconstitution inflammatory syndrome? AIDS Res Ther 2009 0.88
105 Stimulation of A2A-adenosine receptors after myocardial infarction suppresses inflammatory activation and attenuates contractile dysfunction in the remote left ventricle. Am J Physiol Heart Circ Physiol 2005 0.88
106 Phosphorylation of p27(KIP1) homologs KRP6 and 7 by SNF1-related protein kinase-1 links plant energy homeostasis and cell proliferation. Plant J 2013 0.88
107 Start improving the quality of care for people with type 2 diabetes through a general practice support program: a cluster randomized trial. Diabetes Res Clin Pract 2010 0.87
108 Uremia suppresses immune signal-induced CYP27B1 expression in human monocytes. Am J Nephrol 2012 0.87
109 A cluster randomized trial to improve adherence to evidence-based guidelines on diabetes and reduce clinical inertia in primary care physicians in Belgium: study protocol [NTR 1369]. Implement Sci 2008 0.87
110 Vitamin D for infections. Curr Opin Endocrinol Diabetes Obes 2014 0.87
111 Cardiovascular risk factors and complications associated with albuminuria and impaired renal function in insulin-treated diabetes. J Diabetes Complications 2013 0.86
112 1,25-dihydroxyvitamin D3 and a superagonistic analog in combination with paclitaxel or suberoylanilide hydroxamic acid have potent antiproliferative effects on anaplastic thyroid cancer. J Steroid Biochem Mol Biol 2010 0.86
113 Vitamin D and diabetes. Rheum Dis Clin North Am 2012 0.86
114 Characterization of the condensin component Cnap1 and protein kinase Melk as novel E2F target genes down-regulated by 1,25-dihydroxyvitamin D3. J Biol Chem 2005 0.86
115 Quality indicators for type-2 diabetes care in practice guidelines: an example from six European countries. Prim Care Diabetes 2006 0.86
116 Altered expression of key players in vitamin D metabolism and signaling in malignant and benign thyroid tumors. J Histochem Cytochem 2012 0.85
117 Endometrial and peritoneal expression of aromatase, cytokines, and adhesion factors in women with endometriosis. Fertil Steril 2007 0.85
118 Proteome analysis demonstrates profound alterations in human dendritic cell nature by TX527, an analogue of vitamin D. Proteomics 2009 0.85
119 Traffic air pollution and oxidized LDL. PLoS One 2011 0.85
120 Acute shock induced by antigen vaccination in NOD mice. Diabetes 2003 0.85
121 Monocytic expression behavior of cytokines in diabetic patients upon inflammatory stimulation. Ann N Y Acad Sci 2004 0.85
122 No evidence for a role of rare CYP27B1 functional variations in multiple sclerosis. Ann Neurol 2013 0.84
123 Mechanisms for the selective action of Vitamin D analogs. J Steroid Biochem Mol Biol 2005 0.84
124 The role of blood glucose monitoring in non-insulin treated type 2 diabetes: what is the evidence? Prim Care Diabetes 2012 0.84
125 High glucose induces dysfunction in insulin secretory cells by different pathways: a proteomic approach. J Proteome Res 2010 0.84
126 Otelixizumab in the treatment of type 1 diabetes mellitus. Immunotherapy 2011 0.84
127 Posttranslational modifications of proteins in type 1 diabetes: the next step in finding the cure? Diabetes 2012 0.84
128 Monitoring modifiable cardiovascular risk in type 2 diabetes care in general practice: the use of an aggregated z-score. Med Care 2010 0.83
129 The vitamin D analog TX527 ameliorates disease symptoms in a chemically induced model of inflammatory bowel disease. J Steroid Biochem Mol Biol 2012 0.83
130 Combined 'en bloc' liver and pancreas transplantation in patients with liver disease and type 1 diabetes mellitus. Am J Transplant 2004 0.83
131 Functional beta-cell mass and insulin sensitivity is decreased in insulin-independent pancreas-kidney recipients. Transplantation 2009 0.83
132 1α,25-Dihydroxyvitamin D3 and its analogs as modulators of human dendritic cells: a comparison dose-titration study. J Steroid Biochem Mol Biol 2012 0.82
133 IL-10- and IL-12-independent down-regulation of allergic sensitization by stimulation of CD40 signaling. J Immunol 2006 0.82
134 A combined "omics" approach identifies N-Myc interactor as a novel cytokine-induced regulator of IRE1 protein and c-Jun N-terminal kinase in pancreatic beta cells. J Biol Chem 2014 0.82
135 Light and oxygen are not required for harpin-induced cell death. J Biol Chem 2007 0.81
136 Effect of recombinant human TNF-binding protein-1 and GnRH antagonist on mRNA expression of inflammatory cytokines and adhesion and growth factors in endometrium and endometriosis tissues in baboons. Fertil Steril 2007 0.81
137 Early presence of regulatory cells in transplanted rats rendered tolerant by donor-specific blood transfusion. J Immunol 2005 0.81
138 An integrated proteomics and genomics analysis to unravel a heterogeneous platelet secretion defect. J Proteomics 2011 0.81
139 Calcium insufficiency accelerates type 1 diabetes in vitamin D receptor-deficient nonobese diabetic (NOD) mice. Endocrinology 2011 0.81
140 IL-17A increases the expression of proinflammatory chemokines in human pancreatic islets. Diabetologia 2013 0.81
141 Effects of vitamin D on antigen-specific and non-antigen-specific immune modulation: relevance for type 1 diabetes. Pediatr Diabetes 2012 0.81
142 Economic aspects of diabetic foot care in a multidisciplinary setting: a review. Diabetes Metab Res Rev 2007 0.81
143 Straight from D-Heart: vitamin D status and cardiovascular disease. Curr Opin Lipidol 2012 0.80
144 Impact of vitamin D receptor activity on experimental autoimmune prostatitis. J Autoimmun 2009 0.80
145 Two-dimensional gel proteome reference map of INS-1E cells. Proteomics 2011 0.80
146 Post-transplant lymphoma of the pancreatic allograft in a kidney-pancreas transplant recipient: a misleading presentation. Nephrol Dial Transplant 2006 0.80
147 Role of the saturated nonesterified fatty acid palmitate in beta cell dysfunction. J Proteome Res 2012 0.80
148 Beta-cell transplantation restores metabolic control and quality of life in a patient with subcutaneous insulin resistance. Diabetes Care 2004 0.80
149 Relation between disease phenotype and HLA-DQ genotype in diabetic patients diagnosed in early adulthood. J Clin Endocrinol Metab 2002 0.80
150 1alpha,25-Dihydroxyvitamin D3-induced down-regulation of the checkpoint proteins, Chk1 and Claspin, is mediated by the pocket proteins p107 and p130. J Steroid Biochem Mol Biol 2006 0.80
151 Comparison of sirolimus alone with sirolimus plus tacrolimus in type 1 diabetic recipients of cultured islet cell grafts. Transplantation 2008 0.80
152 Treatment outcomes after initiation of exenatide twice daily or insulin in clinical practice: 12-month results from CHOICE in six European countries. Diabetes Metab Syndr Obes 2013 0.80
153 A proposal for the use of uniform diagnostic criteria for gestational diabetes in Europe: an opinion paper by the European Board & College of Obstetrics and Gynaecology (EBCOG). Diabetologia 2015 0.79
154 Oleate-induced beta cell dysfunction and apoptosis: a proteomic approach to glucolipotoxicity by an unsaturated fatty acid. J Proteome Res 2011 0.79
155 Understanding dendritic cell biology and its role in immunological disorders through proteomic profiling. Proteomics Clin Appl 2009 0.79
156 Influence of chronic comorbidity and medication on the efficacy of treatment in patients with diabetes in general practice. Br J Gen Pract 2013 0.79
157 Novel insights into the global proteome responses of insulin-producing INS-1E cells to different degrees of endoplasmic reticulum stress. J Proteome Res 2010 0.79
158 1,25-dihydroxycholecalciferol: endocrinology meets the immune system. Proc Nutr Soc 2002 0.79
159 The Belgian Diabetes in Pregnancy Study (BEDIP-N), a multi-centric prospective cohort study on screening for diabetes in pregnancy and gestational diabetes: methodology and design. BMC Pregnancy Childbirth 2014 0.79
160 Arabidopsis monomeric G-proteins, markers of early and late events in cell differentiation. Int J Dev Biol 2009 0.79
161 Microarray analysis of 1alpha,25-dihydroxyvitamin D3-treated MC3T3-E1 cells. J Steroid Biochem Mol Biol 2004 0.79
162 NOD bone marrow-derived dendritic cells are modulated by analogs of 1,25-dihydroxyvitamin D3. J Steroid Biochem Mol Biol 2004 0.79
163 Occurrence of autoimmunity after xenothymus transplantation in T-cell-deficient mice depends on the thymus transplant technique. Transplantation 2008 0.79
164 Vitamin D in thyroid tumorigenesis and development. Prog Histochem Cytochem 2013 0.79
165 Early accumulation of interferon-gamma in grafts tolerized by donor-specific blood transfusion: friend or enemy? Transplantation 2004 0.79
166 Gestational diabetes: update of screening strategy and diagnostic criteria. Curr Opin Obstet Gynecol 2013 0.79
167 Vitamin D resistance. Best Pract Res Clin Endocrinol Metab 2006 0.79
168 The importance of glycemic control: how low should we go with HbA1c? Start early, go safe, go low. J Diabetes Complications 2010 0.79
169 Gender differences in the psychological adjustment to type 1 diabetes mellitus: an explorative study. Patient Educ Couns 2002 0.79
170 Type 2 diabetes: Gaining insight into the disease process using proteomics. Proteomics Clin Appl 2008 0.78
171 Amplification of Nicotiana sylvestris mitochondrial subgenomes is under nuclear control and is associated with phenotypic changes. Genetica 2003 0.78
172 Two-year efficacy and safety of AIR inhaled insulin in patients with type 1 diabetes: An open-label randomized controlled trial. Diabetes Technol Ther 2009 0.78
173 Patient-reported outcomes among patients using exenatide twice daily or insulin in clinical practice in six European countries: the CHOICE prospective observational study. Health Qual Life Outcomes 2013 0.78
174 Graves hyperthyroidism after stopping immunosuppressive therapy in type 1 diabetic Islet cell recipients with pretransplant TPO autoantibodies. Diabetes Care 2009 0.78
175 Regulatory cell-mediated tolerance does not protect against chronic rejection. Transplantation 2003 0.78
176 Regulatory cells, TH1/TH2 unbalance, and antibody-induced chronic rejection in operational tolerance induced by donor-specific blood transfusion. Transplantation 2005 0.78
177 Increased beta-cell mass by islet transplantation and PLAG1 overexpression causes hyperinsulinemic normoglycemia and hepatic insulin resistance in mice. Diabetes 2010 0.78
178 How can macroscopically normal peritoneum contribute to the pathogenesis of endometriosis? Fertil Steril 2011 0.78
179 Critical review of oral drug treatments for diabetic neuropathic pain-clinical outcomes based on efficacy and safety data from placebo-controlled and direct comparative studies. Diabetes Metab Res Rev 2005 0.77
180 Prospects for vitamin D receptor modulators as candidate drugs for cancer and (auto)immune diseases. Recent Results Cancer Res 2003 0.77
181 Quantification of chemokines by real-time reverse transcriptase PCR: applications in type 1 diabetes. Expert Rev Mol Diagn 2006 0.77
182 Vitamin D action: lessons from VDR and Cyp27b1 null mice. Pediatr Endocrinol Rev 2013 0.77
183 Resource use and costs of exenatide bid or insulin in clinical practice: the European CHOICE study. Clinicoecon Outcomes Res 2013 0.77
184 1,25-Dihydroxyvitamin D3 alters the profile of bone marrow-derived dendritic cells of NOD mice. Ann N Y Acad Sci 2004 0.77
185 Crucial role of interferon-gamma in experimental autoimmune prostatitis. J Urol 2010 0.76
186 Antiproliferative and calcemic actions of trans-decalin CD-ring analogs of 1,25-dihydroxyvitamin D3. Anticancer Res 2009 0.76
187 Blockade of CTLA-4 (CD152) enhances the murine antibody response to pneumococcal capsular polysaccharides. J Leukoc Biol 2005 0.76
188 Glucagon-like peptide-1 protects human islets against cytokine-mediated β-cell dysfunction and death: a proteomic study of the pathways involved. J Proteome Res 2013 0.76
189 Paradoxical early upregulation of intragraft Th1 cytokines is associated with graft acceptance following donor-specific blood transfusion. Transpl Int 2003 0.76
190 The influence of maternal BMI and age in twin pregnancies on insulin resistance in the offspring. Diabetes Care 2002 0.76
191 Protein-induced changes during the maturation process of human dendritic cells: A 2-D DIGE approach. Proteomics Clin Appl 2008 0.76
192 Vitamin D deficiency is not good for you. Diabetes Care 2011 0.76
193 Antigen-based vs. systemic immunomodulation in type 1 diabetes: the pros and cons. Islets 2013 0.76
194 1alpha,25-Dihydroxyvitamin D3 modulates the murine antibody response to pneumococcal capsular polysaccharide serotype 3 through IL-12. Eur J Immunol 2005 0.76
195 A decision support tool for appropriate glucose-lowering therapy in patients with type 2 diabetes. Diabetes Technol Ther 2014 0.76
196 Late CD8+ T cell-dependent xenoantibody production in innate tolerant nude rats after hamster islet grafting but not after hamster heart grafting. Transplantation 2008 0.76
197 Minimal functional β-cell mass in intraportal implants that reduces glycemic variability in type 1 diabetic recipients. Diabetes Care 2013 0.76
198 Murine bone marrow chimeras developing autoimmunity after CTLA-4-blockade show an expansion of T regulatory cells with an activated cytokine profile. Immunol Lett 2010 0.76
199 Seasonality of birth in patients with type 1 diabetes. Lancet 2002 0.75
200 Type 1 diabetes: entering the proteomic era. Expert Rev Proteomics 2006 0.75
201 T-cell mediated late increase in bronchial tone after allergen provocation in a murine asthma model. Clin Immunol 2008 0.75
202 Preservation of recall immunity in anti-CD3-treated recent onset type 1 diabetes patients. Diabetes Metab Res Rev 2011 0.75
203 Early alteration of kidney function in nonuremic type 1 diabetic islet transplant recipients under tacrolimus-mycophenolate therapy. Transplantation 2014 0.75
204 Reversal of hyperglycemia by insulin-secreting rat bone marrow- and blastocyst-derived hypoblast stem cell-like cells. PLoS One 2013 0.75
205 Hen egg white lysozyme vaccination induces acute shock in NOD mice. Ann N Y Acad Sci 2003 0.75
206 Age and early graft function relate with risk-benefit ratio of allogenic islet transplantation under Anti-thymocyte globulin - Mycophenolate mofetil - Tacrolimus immune suppression. Transplantation 2016 0.75
207 The sunshine hormone vitamin D and its association with type 1 diabetes. Discov Med 2005 0.75
208 Immune and cell therapy in type 1 diabetes: too little too late? Expert Opin Biol Ther 2011 0.75
209 Clinical Immunosuppressants Inhibit Inflammatory, Proliferative, and Reprogramming Potential, But Not Angiogenesis of Human Pancreatic Duct Cells. Cell Transplant 2014 0.75
210 Glycated hemoglobin in pregnancies at increased risk for gestational diabetes mellitus. Eur J Obstet Gynecol Reprod Biol 2012 0.75
211 Corrigendum: Analysis of self-antigen specificity of islet-infiltrating T cells from human donors with type 1 diabetes. Nat Med 2017 0.75
212 Performance of strip-based glucose meters and cassette-based blood gas analyzer for monitoring glucose levels in a surgical intensive care setting. Clin Chem Lab Med 2016 0.75
213 Corrigendum: Analysis of self-antigen specificity of islet-infiltrating T cells from human donors with type 1 diabetes. Nat Med 2017 0.75
214 Evidence that norflurazon affects chloroplast lipid unsaturation in soybean leaves (Glycine max L.). J Agric Food Chem 2009 0.75
215 Leptin-adiponectin ratio in pre-diabetic patients undergoing percutaneous coronary intervention. Acta Cardiol 2015 0.75
216 An uncommon tumor in a renal graft recipient: a diagnostic and therapeutic challenge. Am J Kidney Dis 2002 0.75
217 Pdx1- and Ngn3-Cre-mediated PLAG1 expression in the pancreas leads to endocrine hormone imbalances that affect glucose metabolism. Cell Transplant 2011 0.75
218 Proteomics as a tool to discover biomarkers for the prediction of diabetic complications. Expert Opin Med Diagn 2008 0.75